FRESENIUS KABI USA FDA Approval ANDA 211211

ANDA 211211

FRESENIUS KABI USA

FDA Drug Application

Application #211211

Application Sponsors

ANDA 211211FRESENIUS KABI USA

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION5GM/100ML;900MG/100ML0DEXTROSE 5% AND SODIUM CHLORIDE 0.9%DEXTROSE; SODIUM CHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2020-09-14UNKNOWN

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

FRESENIUS KABI USA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211211
            [companyName] => FRESENIUS KABI USA
            [docInserts] => ["",""]
            [products] => [{"drugName":"DEXTROSE 5% AND SODIUM CHLORIDE 0.9%","activeIngredients":"DEXTROSE; SODIUM CHLORIDE","strength":"5GM\/100ML;900MG\/100ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/14\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-09-14
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.